Ships on ICE, Please choose 2nd day Shipping for this item. For Canada customers, please choose Worldwide Saver as the shipping method.
RECOMBITEK® EQUINE WEST NILE VIRUS
West Nile Virus Vaccine, Live Canarypox Vector
Contents: RECOMBITEK® Equine West Nile Virus contains a lyophilized recombinant canarypox vectored West Nile Virus vaccine plus a sterile liquid diluent. A canarypox vector has been modified using recombinant technology to express the desired antigens capable of stimulating a protective immune response to West Nile Virus. After inoculation, the vector does not multiply in the horse, but does express the protective proteins. As a consequence, these components induce an immune status against West Nile Virus. Safety and immunogenicity of this vaccine have been demonstrated by vaccination and challenge tests in susceptible horses.
INDICATIONS: RECOMBITEK® WNV is recommended for the vaccination of healthy horses as an aid in the prevention of viremia due to West Nile Virus infection.
DOSAGE: Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject a 1 ml dose by intramuscular route. For primary vaccination, revaccinate with a second 1 ml dose of this product 4 to 6 weeks later. Annual revaccination with a single dose is recommended.
PRECAUTIONS: Store at 2-7°C (35-45°F). For the preparation and administration of the vaccine, use sterile and antiseptic-free and/or disinfectant-free material. Burn container and all unused contents. Contains gentamicin as a preservative. Do not vaccinate within 21 days prior to slaughter. As with any vaccine, a hypersensitivity reaction may occur, which may require appropriate symptomatic treatment.
SOLD TO VETERINARIANS ONLY.
For Veterinary Use Only.
|10 Doses||10 x 1 dose (1 mL)|
|10 x 1 Dose, Lyophilized|
|10 x 1 mL, Sterile Water|
|25 Doses||5 x 5 dose (5 mL)|
|5 x 5 Dose, Lyophilized|
|5 x 5 mL, Sterile Diluent|